119 related articles for article (PubMed ID: 34812573)
1. High serum fibroblast growth factor 21 is associated with inferior hepatocellular carcinoma survival: A prospective cohort study.
Liu ZY; Luo Y; Fang AP; Wusiman M; He TT; Liu XZ; Yishake D; Chen S; Lu XT; Zhang YJ; Zhu HL
Liver Int; 2022 Mar; 42(3):663-673. PubMed ID: 34812573
[TBL] [Abstract][Full Text] [Related]
2. Serum folate concentrations at diagnosis are associated with hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort study.
Fang AP; Liu ZY; Liao GC; Chen PY; Wang XY; Zhang DM; Luo Y; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
Br J Nutr; 2019 Jun; 121(12):1376-1388. PubMed ID: 30935429
[TBL] [Abstract][Full Text] [Related]
3. Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort.
Fang AP; Chen PY; Wang XY; Liu ZY; Zhang DM; Luo Y; Liao GC; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
Int J Cancer; 2019 Jun; 144(11):2823-2832. PubMed ID: 30426509
[TBL] [Abstract][Full Text] [Related]
4. Serum Bioavailable, Rather Than Total, 25-hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival.
Fang AP; Long JA; Zhang YJ; Liu ZY; Li QJ; Zhang DM; Luo Y; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhu HL
Hepatology; 2020 Jul; 72(1):169-182. PubMed ID: 31677282
[TBL] [Abstract][Full Text] [Related]
5. Serum choline is associated with hepatocellular carcinoma survival: a prospective cohort study.
Liu ZY; Yishake D; Fang AP; Zhang DM; Liao GC; Tan XY; Zhang YJ; Zhu HL
Nutr Metab (Lond); 2020; 17():25. PubMed ID: 32256673
[TBL] [Abstract][Full Text] [Related]
6. Dietary protein and prognosis of hepatocellular carcinoma: a prospective cohort study.
Yishake D; He TT; Liu ZY; Chen S; Luo Y; Liu XZ; Huang RZ; Lan QY; Fang AP; Zhu HL
Food Funct; 2021 Nov; 12(22):11568-11576. PubMed ID: 34709274
[TBL] [Abstract][Full Text] [Related]
7. Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases.
Wu L; Pan Q; Wu G; Qian L; Zhang J; Zhang L; Fang Q; Zang G; Wang Y; Lau G; Li H; Jia W
Sci Rep; 2017 Nov; 7(1):16482. PubMed ID: 29184085
[TBL] [Abstract][Full Text] [Related]
8. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
9. Dietary intake of one-carbon metabolism-related nutrients and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort.
He TT; Xiao HW; Wusiman M; Yishake D; Fang AP; Luo Y; Liu XZ; Liu ZY; Zhu HL
Food Funct; 2022 Aug; 13(15):8081-8090. PubMed ID: 35792143
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
Li X; Wu X; Jia Y; Fu J; Zhang L; Jiang T; Liu J; Wang G
J Diabetes Res; 2021; 2021():3715026. PubMed ID: 34660809
[TBL] [Abstract][Full Text] [Related]
11. Insight to the association among fibroblast growth factor 21, non-alcoholic fatty liver disease and cardiovascular outcomes: A population-based study.
Shen Y; Hu T; Tan H; Xu Y; Wang Y; Ma X; Bao Y
Cytokine; 2023 Oct; 170():156318. PubMed ID: 37549489
[TBL] [Abstract][Full Text] [Related]
12. FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma: A meta-analysis.
Zhang Y; Wang R; Yang X
Medicine (Baltimore); 2018 Dec; 97(51):e13696. PubMed ID: 30572498
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor gene polymorphisms, bioavailable 25-hydroxyvitamin D, and hepatocellular carcinoma survival.
Shu J; Zhang M; Dong X; Long J; Li Y; Tan P; He T; Giovannucci EL; Zhang X; Zhou Z; Xu Y; Xu X; Peng T; Lu J; Chen M; Zhu H; Zhang Y; Fang A
J Natl Cancer Inst; 2024 Jun; ():. PubMed ID: 38830043
[TBL] [Abstract][Full Text] [Related]
15. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.
Simon TG; King LY; Chong DQ; Nguyen LH; Ma Y; VoPham T; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Khalili H; Chung RT; Zhang X; Chan AT
Hepatology; 2018 May; 67(5):1797-1806. PubMed ID: 29152763
[TBL] [Abstract][Full Text] [Related]
16. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis.
Vidal RIO; Vidal EIO; Pereira BB; Assane CC; Ribeiro A; do Nascimento EM; Romeiro FG; Ribeiro Filho J
Biomed Res Int; 2020; 2020():1487593. PubMed ID: 33134370
[TBL] [Abstract][Full Text] [Related]
18. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
[TBL] [Abstract][Full Text] [Related]
19. Association between dietary patterns and prognosis of hepatocellular carcinoma in the Guangdong liver cancer cohort study.
Luo Y; Zhang YJ; Zhang DM; Yishake D; Liu ZY; Chen MS; Wang F; Zhou ZG; Long JA; Zhong RH; Chen S; Lu XT; Li SY; He TT; Luo Y; Fang AP; Zhu HL
Hepatol Res; 2020 Oct; 50(10):1164-1175. PubMed ID: 32691459
[TBL] [Abstract][Full Text] [Related]
20. Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort.
Huber Y; Bierling F; Labenz C; Koch S; Schmidtmann I; Kloeckner R; Schotten S; Huber T; Lang H; Woerns MA; Galle PR; Weinmann A; Weinmann-Menke J
BMC Cancer; 2018 Jul; 18(1):774. PubMed ID: 30064393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
